Staphylococcus aureus is a common cause of human infection, and emergence of vancomycin-resistance S. aureus is a great concern for treatment of methicillin-resistant S. aureus,(MRSA) in recent years (MRSA). Here, we report the isolation of high-level VRSA. Materials and Methods S. aureus was isolated from foot ulcer of a diabetic woman in Tehran, Iran. Antibiotic susceptibility was determined according to CLSI guidelines. VanA gene cluster PCR was carried out and PCR amplicon of vanA was sequenced. Results S. aureus had high-level vancomycin-resistant (MIC 512 ≥ µg/ml). Patient's history revealed that VRSA isolate was acquired through community transmission. Only vanA, vanR and vanS genes were amplified in our isolate. Sequencing revealed that the vanA sequence had high similarity to the vanA sequence of Tn1546. Conclusion Although VRSA infection continues to be rare, isolation of community-acquired VRSA is a significant issue and it needs the efforts of public health authorities.
Introduction
Staphylococcus aureus is a common cause of hospital and community-acquired infections. Because of the spread of multidrug-resistant Gram-positive bacteria as well as methicilinresistant S. aureus (MRSA), glycopeptide antibiotics, vancomycin and teicoplanin are used to treat severe staphylococcal infections (1) . The first clinical vancomycin-resistance S. aureus (MIC ≥ 32 µg/mL) was reported from Michigan, USA in 2002 (2) . It seems that the development of vancomycin-resistant enterococci (VRE) in 1988 led to the emergence of VRSA through acquisition of the VanA gene cluster from Entercoccus spp (3). The first detection of the VRSA in Iran was in 2007 (4) and this report describes clinical isolate of community-acquired vancomycinresistant S. aureus from a diabetic patient in Iran with the vancomycin MIC 512 ≥ µg/ml.
Materials and Methods

Bacterial isolate
A 51-year-old female with a history of diabetes mellitus was admitted to the Surgery Department of Taleghani Hospital, Tehran. Incision and drainage of the abscess was performed, and discharge was sent to the laboratories for microbiological and molecular investigation. Patient 
Results
The isolate was identified as S. aureus and it was resistant to vancomycin, teicoplanin, penicillin, oxacillin, ceftriaxone, erythromycin, clindamycin, amikacin, co-trimoxazole, chloramphenicol, amoxicillin, and sensitive to imepenem. The isolate showed high-level vancomycin resistance (512 µg/ml).
Based on the resistance to glycopeptide antibiotics, the S. aureus isolate expressed VanA phenotype.
Patient's history revealed that this isolate was a community-acquired VRSA. From VanA gene cluster, only PCR products of vanA, vanR and vanS were amplified from extracted DNA with expected size.
DNA and the inferred amino acid sequences were compared using DNAsis (version 2.5; Hitachi). DNA sequence analysis revealed that this strain's vanA sequence had high similarity to the vanA sequence of Tn1546 (M97297). The partial sequence of vanA gene has been submitted to GenBank (GQ273978). 
Discussion
There are limited reports about isolation of VRSA from clinical specimens in all over the world and among these isolates a few of them were community-acquired VRSA (8) . To the best of our knowledge, it is the first report of community-acquired of vancomycin and methicillin-resistant S. aureus in Tehran, Iran.
According to the in vitro transfer of vanA gene from enterococci to S. aureus (8) , we suspect the possibility of transformation of vancomycin resistance gene (vanA) from VRE to Staphylococci spp.
In this study there were significant differences between previously described VanA gene cluster among enterococci and our isolate. Although the vanA, vanR, vanS, vanH and vanX genes are essential for the expression of VanA phenotype, according to the previous study (9) , the difficulties with amplification of vanH and vanX in the vanA gene cluster may be due to disruptions of these regions with insertion sequences (ISs).
Prevention of emergence and transmission of VRSA in each community is needed. So, use of proper infection-control practices, appropriate antimicrobial agent management, maintaining a clean environment and increased awareness can control the spread of antimicrobial-resistant microorganisms, including VRSA.
Conclusion
This report describes a community-acquired and multidrug-resistant S. aureus isolated from a diabetic patient in Tehran, Iran. Among antibiotics used in this study, co-resistance to oxacillin and vancomycin is a critical issue because vancomycin is the first-line antimicrobial agent for the treatment of infection with MRSA.
